September 4, 2024 - Bioactivelibrary

A: Empagliflozin (BI 10773), a potent and selective SGLT-2 inhibitor, induces dose-dependent

Chemexpress September 4, 2024 0 Comments

A: Empagliflozin (BI 10773), a potent and selective SGLT-2 inhibitor, induces dose-dependent glucosuria in healthier subjects. Clinical Pharm in Drug Dev 2013. doi:10.1002/cpdd.16 . 11. Cubeddu LX: QT prolongation and…

Uncategorized

C antisense oligonucleotide delivery, the flanking intron sequences and the dystrophin

Chemexpress September 4, 2024 0 Comments

C antisense oligonucleotide delivery, the flanking intron sequences plus the dystrophin exon are spliced out, resulting inside the restoration of an in-frame GFP transcript. C2C12E50 cells had been grown in…

A: Empagliflozin (BI 10773), a potent and selective SGLT-2 inhibitor, induces dose-dependent

C antisense oligonucleotide delivery, the flanking intron sequences and the dystrophin

You Missed

Myf-5 Rabbit Polyclonal Antibody

NDUAB Rabbit Polyclonal Antibody

Myosin Light Chain 2 Recombinant Rabbit Monoclonal Antibody [SN67-09]

Biotin Conjugated Mouse IL-1 beta Recombinant Rabbit Monoclonal Antibody [PSH04-67]